Search Results - "Eteläinen, Tony"
-
1
Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α‑Synuclein Mouse Models of Parkinson’s Disease
Published in Journal of medicinal chemistry (08-06-2023)“…Prolyl oligopeptidase (PREP) is a widely distributed serine protease in the human body cleaving proline-containing peptides; however, recent studies suggest…”
Get full text
Journal Article -
2
Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model
Published in Neuropharmacology (01-11-2022)“…Parkinson's disease (PD) is characterized by degeneration of nigrostriatal dopaminergic neurons and accumulation of α-synuclein (αSyn) as Lewy bodies…”
Get full text
Journal Article -
3
Repeated Ethanol Exposure Alters DNA Methylation Status and Dynorphin/Kappa-Opioid Receptor Expression in Nucleus Accumbens of Alcohol-Preferring AA Rats
Published in Frontiers in genetics (24-11-2021)“…Growing evidence suggests that epigenetic mechanisms, such as DNA methylation and demethylation, and histone modifications, are involved in the development of…”
Get full text
Journal Article -
4
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy
Published in Science translational medicine (12-04-2023)“…Tauopathies are neurodegenerative diseases that are characterized by accumulation of hyperphosphorylated tau protein, higher-order aggregates, and tau…”
Get more information
Journal Article -
5
Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors
Published in ACS medicinal chemistry letters (12-12-2019)“…4-Phenylbutanoyl-aminoacyl-2(S)-tetrazolylpyrrolidines were studied as prolyl oligopeptidase inhibitors. The compounds were more potent than expected from the…”
Get full text
Journal Article -
6
The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats
Published in European neuropsychopharmacology (01-12-2019)“…•Systemic and intra-accumbens shell JDTic, a κ-antagonist, attenuated the ADE in rats.•A low dose of naltrexone inhibited the ADE and decreased ethanol…”
Get full text
Journal Article -
7
Novel Small‐Molecular Ligands for Prolyl Oligopeptidase to Combat Tauopathies
Published in Alzheimer's & dementia (01-12-2023)“…Background Tauopathies that include e.g. frontotemporal dementia and Alzheimer’s disease, are neurodegenerative diseases characterized by accumulation of…”
Get full text
Journal Article